NMNAT-1 Antibodies

Santa Cruz Biotechnology delivers a wide array of NMNAT-1 monoclonal antibodies for research focused on understanding NMNAT-1's role in cellular processes. NMNAT-1 monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Nicotinamide adenine dinucleotide (NAD+) is a crucial coenzyme in cellular metabolism, and NMNAT-1 plays a significant role in its synthesis. By converting nicotinamide mononucleotide (NMN) to NAD+, NMNAT-1 is essential for maintaining cellular energy levels and regulating various metabolic pathways. NMNAT-1 has emerged as a key focus in research related to neurodegenerative diseases and metabolic disorders. Researchers worldwide utilize NMNAT-1 monoclonal antibodies to explore cellular pathways and molecular mechanisms. Current studies highlight NMNAT-1's importance in maintaining cellular health and energy homeostasis. Understanding NMNAT-1's function continues to reveal new insights into disease mechanisms and potential therapeutic approaches. Santa Cruz Biotechnology monoclonal antibodies support researchers in advancing scientific understanding of NMNAT-1's role in health and disease.